SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 3 filers reported holding SEATTLE GENETICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,139,000 | +0.4% | 36,483 | -12.9% | 0.08% | -1.2% |
| Q2 2020 | $7,114,000 | +78.6% | 41,869 | +21.3% | 0.08% | +71.4% |
| Q1 2020 | $3,983,000 | -14.6% | 34,518 | -15.5% | 0.05% | +6.5% |
| Q4 2019 | $4,665,000 | -21.0% | 40,828 | -40.9% | 0.05% | -23.3% |
| Q3 2019 | $5,903,000 | +23.8% | 69,126 | +0.3% | 0.06% | +39.5% |
| Q2 2019 | $4,768,000 | +4.5% | 68,897 | +10.6% | 0.04% | +7.5% |
| Q1 2019 | $4,561,000 | +29.6% | 62,280 | +0.3% | 0.04% | +21.2% |
| Q4 2018 | $3,519,000 | -20.0% | 62,109 | +8.9% | 0.03% | -10.8% |
| Q3 2018 | $4,398,000 | +15.7% | 57,032 | -0.4% | 0.04% | +8.8% |
| Q2 2018 | $3,802,000 | +3.6% | 57,274 | -18.3% | 0.03% | +3.0% |
| Q1 2018 | $3,670,000 | +2.1% | 70,110 | +4.4% | 0.03% | +6.5% |
| Q4 2017 | $3,593,000 | +38.4% | 67,161 | +40.7% | 0.03% | +40.9% |
| Q3 2017 | $2,597,000 | – | 47,732 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |